X. Calvet

J. Gisbert, X. Calvet, M. Chaparro, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Identification of factors that influence tolerance of upper gastrointestinal endoscopy.

M. Rué, A. Montserrat, X. Calvet, 1999, European journal of gastroenterology & hepatology.

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy

J. Gisbert, X. Calvet, I. Ordás, 2010, Gut.

UEG Week 2015 Oral Presentations

J. Gisbert, X. Jouven, H. Sokol, 2015, United European Gastroenterology Journal.

Letter: are idiopathic (non‐NSAID, non‐Helicobacter pylori) ulcers really increasing?

J. Gisbert, X. Calvet, J. Gisbert, 2012, Alimentary pharmacology & therapeutics.

Has H. pylori Prevalence in Bleeding Peptic Ulcer Been Underestimated? A Meta-Regression

J. Gisbert, M. Gallach, J. Sánchez-Delgado, 2011, The American Journal of Gastroenterology.

Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding

J. Gisbert, X. Calvet, J. Piqué, 2008, Alimentary Pharmacology and Therapeutics.

Eradication of Helicobacter pylori for the Prevention of Peptic Ulcer Rebleeding

J. Gisbert, X. Calvet, J. Piqué, 2007, Helicobacter.

Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy for the prevention of recurrent bleeding from peptic ulcer

J. Gisbert, X. Calvet, F. Carballo, 2004 .

Good diagnostic accuracy of a chemiluminescent immunoassay in stool samples for diagnosis of Helicobacter pylori infection in patients with dyspepsia

A. Montserrat, X. Calvet, S. Lario, 2016, Journal of Investigative Medicine.

Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group

F. Chan, J. Douketis, E. Kuipers, 2019, Annals of Internal Medicine.

Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection

J. Gisbert, J. Sánchez-Delgado, X. Calvet, 2016, Therapeutic advances in gastroenterology.

Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment.

X. Calvet, M. Chaparro, J. Mendoza, 2016, Journal of Crohn's & colitis.

Quality in diagnostic upper gastrointestinal endoscopy for the detection and surveillance of gastric cancer precursor lesions: Position paper of AEG, SEED and SEAP

J. Cubiella, X. Calvet, L. Moreira, 2021, Gastroenterología y Hepatología (English Edition).

How and When Should NSAIDs Be Used for Preventing Post-ERCP Pancreatitis? A Systematic Review and Meta-Analysis

X. Calvet, I. Puig, F. Porta, 2013, PloS one.

Improving Quality of Care in Inflammatory Bowel Disease Through Patients' Eyes: IQCARO Project.

X. Calvet, M. Mínguez, I. Vera, 2020, Inflammatory bowel diseases.

Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units.

J. Gisbert, E. Espin, A. Dosal, 2014, Journal of Crohn's & colitis.

Expression profile of circulating microRNAs in the Correa pathway of progression to gastric cancer

M. Miquel, X. Calvet, S. Lario, 2018, United European gastroenterology journal.

Modified seven‐day, quadruple therapy as a first line Helicobacter pylori treatment

X. Calvet, E. Gené, I. Sanfeliú, 2001 .

What is the optimal length of proton pump inhibitor‐based triple therapies for H. pylori? A cost‐effectiveness analysis

X. Calvet, E. Gené, J. Gisbert, 2001, Alimentary pharmacology & therapeutics.

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta‐analysis of eradication of Helicobacter pylori

J. Gisbert, X. Calvet, J. Pajares, 2000, Alimentary pharmacology & therapeutics.

Four‐Day, Twice Daily, Quadruple Therapy with Amoxicillin, Clarithromycin, Tinidazole and Omeprazole to Cure Helicobacter pylori Infection: A Pilot Study

X. Calvet, R. Comet, L. Titó, 2000, Helicobacter.

Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial

J. Sung, Á. Lanas, X. Calvet, 2013, Scandinavian journal of gastroenterology.

Effects of a multidisciplinary approach on the effectiveness of antiviral treatment for chronic hepatitis C.

M. Gallach, M. Vergara, M. Miquel, 2016, Annals of hepatology.

Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.

J. Gisbert, X. Calvet, M. Piqueras, 2019, Journal of Crohn's & colitis.

Post‐Operative Morbidity and Mortality of a Cohort of Steroid Refractory Acute Severe Ulcerative Colitis: Nationwide Multicenter Study of the GETECCU ENEIDA Registry

X. Calvet, I. Ordás, J. Panés, 2018, The American Journal of Gastroenterology.

Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C

M. Vergara, M. Miquel, M. Casas, 2015, European journal of gastroenterology & hepatology.

Evaluation of Four Different Fecal Tests for Determination of Cure After Helicobacter pylori Treatment

A. Montserrat, A. Dosal, X. Calvet, 2006, Journal of clinical gastroenterology.

Fourteen‐day high‐dose esomeprazole, amoxicillin and metronidazole as third‐line treatment for Helicobacter pylori infection

J. Gisbert, X. Calvet, J. Barrio, 2017, International journal of clinical practice.

Diarrhea as a presenting symptom of hepatocellular carcinoma

J. Bruix, X. Calvet, M. Solé, 1990, Digestive Diseases and Sciences.

Stool antigen for the diagnosis of Helicobacter pylori infection in cirrhosis: comparative usefulness of three different methods

B. Dalmau, X. Calvet, M. Gil, 2003, Alimentary pharmacology & therapeutics.

Evaluation of Helicobacter pylori diagnostic methods in patients with liver cirrhosis

E. Musulen, B. Dalmau, X. Calvet, 2002, Alimentary pharmacology & therapeutics.

Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis.

B. Dalmau, X. Calvet, M. Gil, 1997, Journal of hepatology.

Clinical usefulness of lanthanum carbonate for serum phosphate control in difficult patients

X. Calvet, J. Almirall, V. Esteve, 2012, International Urology and Nephrology.

Heterogeneity in pharmacological treatment and outcomes in Crohn’s disease patients in Catalonia: a population-based observational study

G. Kaplan, M. Clèries, X. Calvet, 2022, Annals of medicine.

Rabeprazole‐based therapies in Helicobacter pylori eradication

X. Calvet, J. Gisbert, J. Pajares, 2003 .

Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn's disease

F. Casellas, A. Montserrat, M. Vergara, 2006, Inflammatory bowel diseases.

Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases.

J. Bruix, X. Calvet, R. Molina, 1991, Clinical chemistry.

Cancer Antigen 125 in Serumand AsciticFluidof PatientswithLiverDiseases

X. Calvet, R. Molina, J. Bosch, 1991 .

Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP

J. Cubiella, X. Calvet, L. Moreira, 2021 .

Re: peppers at treatment for Helicobacter pylori infection

X. Calvet, E. Gené, C. Carod, 2000, American Journal of Gastroenterology.

Cost-Minimization Analysis Favours Intravenous Ferric Carboxymaltose over Ferric Sucrose for the Ambulatory Treatment of Severe Iron Deficiency

M. Miquel, A. Dosal, X. Calvet, 2012, PloS one.

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

J. Gisbert, F. Rodríguez‐Artalejo, X. Calvet, 2021, Journal of clinical medicine.

Prevalence, incidence and mortality of inflammatory bowel disease in Catalonia. A population-based analysis

M. Clèries, X. Calvet, C. Pontes, 2018, Annals of medicine.

Perception of disease burden and treatment satisfaction in patients with ulcerative colitis from outpatient clinics in Spain: UC-LIFE survey

X. Calvet, A. López-Sanromán, F. Argüelles-Arias, 2016, European journal of gastroenterology & hepatology.

M. Vergara, X. Calvet, F. Gomollón, 2015, United European gastroenterology journal.

Optimising Acid Inhibition Treatment

X. Calvet, F. Gomollón, 2012, Drugs.

Effectiveness of Adalimumab in Perianal Fistulas in Crohn’s Disease Patients Naive to Anti-TNF Therapy

J. Gisbert, X. Calvet, M. Piqueras, 2015, Journal of clinical gastroenterology.

Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.

J. Gisbert, X. Calvet, F. Carballo, 2004, Alimentary pharmacology & therapeutics.

[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference].

J. Gisbert, X. Calvet, J. Mones, 2005, Medicina clinica.

High‐dose, ten‐day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates

J. Gisbert, J. Sánchez-Delgado, X. Calvet, 2012, Alimentary pharmacology & therapeutics.

Diagnosis and Epidemiology of Helicobacter pylori Infection

F. Mégraud, X. Calvet, P. Lehours, 2013, Helicobacter.

Effect of sucralfate on gastric intramucosal pH in critically ill patients

A. Artigas, X. Calvet, P. Saura, 1997, Intensive Care Medicine.

Gastric Intramucosal pH Determination: Limitations of the Technique

A. Artigas, X. Calvet, F. Baigorri, 1995 .

Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial.

J. Gisbert, X. Calvet, J. Barrio, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies

X. Calvet, R. García-Vicuña, X. Juanola, 2021, Gastroenterología y Hepatología (English Edition).

Factors associated with quality of care in inflammatory bowel diseases: a view from patient’s side using the IQCARO quality of care decalogue

X. Calvet, I. Vera, R. Saldaña, 2021, BMC Gastroenterology.

Patient-Evaluated Quality of Care is Related to Better Inflammatory Bowel Disease Outcomes: The IQCARO II Project

X. Calvet, M. Mínguez, I. Vera, 2021, The Patient - Patient-Centered Outcomes Research.

Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU

X. Calvet, M. Piqueras, Miguel A Montoro-Huguet, 2022, Journal of clinical medicine.

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

J. Gisbert, X. Calvet, D. Bernardo, 2018, Digestive Diseases and Sciences.

Relevant infections in inflammatory bowel disease, their relationship with immunosuppressive therapy and their effects on disease mortality.

A. Montserrat, X. Calvet, M. Piqueras, 2019, Journal of Crohn's & colitis.

Accuracy of Monoclonal Stool Tests for Determining Cure of Helicobacter pylori Infection After Treatment

A. Montserrat, M. Gallach, M. Miquel, 2010, Helicobacter.

Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori ﬁrst-line treatment

J. Gisbert, J. Sánchez-Delgado, X. Calvet, 2016 .

Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome.

J. Gisbert, X. Calvet, J. Panés, 2013, Journal of Crohn's & colitis.

Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users

M. Rué, X. Calvet, 2000, Alimentary pharmacology & therapeutics.

Idiopathic pylephlebitis and idiopathic sclerosing peritonitis in a man with protein S deficiency.

E. Musulen, X. Calvet, A. Malet, 2001, Journal of clinical gastroenterology.

Data on individual PCR efficiency values as quality control for circulating miRNAs

X. Calvet, S. Lario, M. J. Ramírez-Lázaro, 2015, Data in brief.

Equipment review: Gastric intramucosal pH measurement

X. Calvet, F. Baigorri, D. Joseph, 1997, Critical care.

Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry

J. Gisbert, F. Rodríguez‐Artalejo, X. Calvet, 2017, The American Journal of Gastroenterology.

Patients’ perceptions of the impact of ulcerative colitis on social and professional life: results from the UC-LIFE survey of outpatient clinics in Spain

X. Calvet, A. López-Sanromán, F. Argüelles-Arias, 2018, Patient preference and adherence.

Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study

J. Gisbert, X. Calvet, M. Chaparro, 2016, Inflammatory bowel diseases.

Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.

J. Gisbert, X. Calvet, M. Andreu, 2014, Journal of Crohn's & colitis.

Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience

J. Gisbert, X. Calvet, J. Panés, 2021, United European gastroenterology journal.

Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case‐control study

J. Gisbert, X. Calvet, E. Cabré, 2018, Alimentary pharmacology & therapeutics.

Time Trends of Crohn’s Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for Surgery

M. Clèries, M. Gallach, M. Vergara, 2020, Journal of clinical medicine.

Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey

X. Calvet, A. López-Sanromán, F. Argüelles-Arias, 2016, Digestive Diseases and Sciences.

Early Use of Azathioprine Has a Steroid Sparing Effect on Recently Diagnosed Crohn's Disease Patients

J. Gisbert, M. Sans, F. Mearin, 2011 .

Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease

J. Gisbert, E. Martí-Bonmatí, X. Calvet, 2017, Journal of Crohn's & colitis.

Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study

J. Gisbert, X. Calvet, J. Panés, 2009, The American Journal of Gastroenterology.

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

J. Gisbert, X. Calvet, M. Piqueras, 2022, Frontiers in Medicine.

Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry

J. Gisbert, X. Calvet, M. Piqueras, 2021, Journal of Crohn's & colitis.

Infliximab salvage therapy after failure of ciclosporin in corticosteroid‐refractory ulcerative colitis: a multicentre study

J. Gisbert, X. Calvet, J. Panés, 2012, Alimentary pharmacology & therapeutics.

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

J. Gisbert, X. Calvet, J. Tosca, 2017, The American Journal of Gastroenterology.

Outcome after a dose "de-intensification" strategy with anti-TNF drugs in patients with Crohn's disease.

J. Gisbert, X. Calvet, M. Chaparro, 2016, Gastroenterologia y hepatologia.

Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents

J. Gisbert, X. Calvet, I. Ordás, 2020, Journal of gastroenterology and hepatology.

Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry

J. Gisbert, X. Calvet, M. Piqueras, 2020, Digestive Diseases and Sciences.

A new validation of the Spanish Work Productivity and Activity Impairment Questionnaire-Crohn's disease version.

F. Casellas, A. Montserrat, M. Vergara, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Analysis of court criteria for awarding disability benefits to patients with Crohn's disease.

A. Montserrat, M. Vergara, X. Calvet, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

J. Gisbert, X. Calvet, M. Dominguez-Cajal, 2019, Inflammatory bowel diseases.

EFFECTIVENESS AND SAFETY OF THE SEQUENTIAL USE OF A SECOND AND THIRD ANTI-TNF AGENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY SHORT TITLE: Sequential use of anti-TNFs in IBD patients AUTHORS

Mariana, J. Gisbert, X. Calvet, 2020 .

Diagnostic accuracy of fine-needle aspiration biopsy in patients with hepatocellular carcinoma

J. Bruix, X. Calvet, A. Maroto, 1989, Digestive Diseases and Sciences.

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients.

F. Casellas, J. Gisbert, X. Calvet, 2018, Gastroenterologia y hepatologia.

Hepatitis C virus infection in patients with nonalcoholic chronic liver disease.

J. Bruix, J. Sánchez-Tapias, X. Calvet, 1990, Annals of internal medicine.

Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts

J. Gisbert, Á. Lanas, F. Mearin, 2022, Frontiers in Medicine.

Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia.

F. Mearin, X. Calvet, J. Calleja, 2016, Technology and health care : official journal of the European Society for Engineering and Medicine.

What is Potent Acid Inhibition, and How Can it be Achieved?

X. Calvet, F. Gomollón, 2012, Drugs.

Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohn's disease version

F. Casellas, A. Montserrat, M. Vergara, 2009, European journal of gastroenterology & hepatology.

Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry

X. Calvet, A. Gutiérrez, F. Mesonero, 2020, Alimentary pharmacology & therapeutics.

Effectiveness and safety of the switch from Remicade to CT-P13 in patients with inflammatory bowel disease.

J. Gisbert, X. Calvet, D. Bernardo, 2019, Journal of Crohn's & colitis.

Increased alphafetoprotein levels in hepatocellular carcinoma: The relationship with tumor size determines its limited value in early detection

J. Bruix, J. Rodés, X. Calvet, 1989 .

Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers.

J. Gisbert, M. Vergara, X. Calvet, 2014, The Cochrane database of systematic reviews.

Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata

Á. Lanas, X. Calvet, J. Calleja, 2014, Scandinavian journal of gastroenterology.

Utility of histology for the diagnosis of portal hypertensive gastroenteropathy. Concordance between the endoscopic image and gastrointestinal biopsies. Role of the CD34 marker

M. Vergara, M. Miquel, M. Casas, 2019, Gastroenterología y Hepatología (English Edition).

Utility of histology for the diagnosis of portal hypertensive gastroenteropathy. Concordance between the endoscopic image and gastrointestinal biopsies. Role of the CD34 marker.

M. Vergara, M. Miquel, M. Casas, 2018, Gastroenterologia y hepatologia.

Repeated Neostigmine Dosage as Palliative Treatment for Chronic Colonic Pseudo-Obstruction in a Patient With Autonomic Paraneoplastic Neuropathy

X. Calvet, Josep M. Martinez, Melcior Martínez, 2003, American Journal of Gastroenterology.

Detection of Helicobacter pylori Microevolution and Multiple Infection from Gastric Biopsies by Housekeeping Gene Amplicon Sequencing

X. Calvet, S. Lario, M. J. Ramírez-Lázaro, 2020, Pathogens.

Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain

X. Calvet, J. Panés, M. Chaparro, 2022, Journal of Crohn's & colitis.

Long-Term Follow-Up of 1,000 Patients Cured of Helicobacter pylori Infection Following an Episode of Peptic Ulcer Bleeding

J. Gisbert, X. Calvet, J. Piqué, 2012, The American Journal of Gastroenterology.

Portal pressure in patients with exudative ascites in the course of acute hepatitis B.

J. Bruix, J. Rodés, X. Calvet, 2008, Liver.

Helicobacter pylori is not a risk factor for hepatic encephalopathy.

X. Calvet, I. Sanfeliú, M. Roqué, 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The Effects of Infliximab or Adalimumab on Vascular Endothelial Growth Factor and Angiopoietin 1 Angiogenic Factor Levels in Inflammatory Bowel Disease: Serial Observations in 37 Patients

J. Gisbert, X. Calvet, M. Chaparro, 2014, Inflammatory bowel diseases.

Management of NSAID-associated peptic ulcer disease

X. Calvet, L. Melcarne, P. García-Iglesias, 2016, Expert review of gastroenterology & hepatology.

Review article: Helicobacter pylori‐negative duodenal ulcer disease

J. Gisbert, X. Calvet, J. Gisbert, 2009, Alimentary pharmacology & therapeutics.

Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp‐EuReg)

F. Mégraud, C. O'Morain, J. Gisbert, 2020, Helicobacter.

Sequential Therapy for Helicobacter pylori Eradication: A Critical Review

F. Mégraud, C. O'Morain, J. Gisbert, 2010, Journal of clinical gastroenterology.

Triple vs. quadruple therapy for treating Helicobacter pylori infection: an updated meta‐analysis

J. Gisbert, X. Calvet, R. Azagra, 2003 .

Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice

Á. Lanas, X. Calvet, L. Bujanda, 2009, The American Journal of Gastroenterology.

Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients

J. Bruix, X. Calvet, M. Solé, 1990, Hepatology.

Risk factors for hepatocellular carcinoma in catalonia, spain

F. X. Bosch, J. Bruix, J. Estève, 1990, International journal of cancer.

Meta‐analysis: proton pump inhibitors vs. H2‐receptor antagonists — their efficacy with antibiotics in Helicobacter pylori eradication

J. Gisbert, X. Calvet, F. Carballo, 2003, Alimentary pharmacology & therapeutics.

Optimum duration of regimens for Helicobacter pylori eradication.

D. Forman, J. Gisbert, F. Bazzoli, 2013, The Cochrane database of systematic reviews.

Ten-Day Sequential Treatment for Helicobacter pylori Eradication in Clinical Practice

J. Gisbert, J. Sánchez-Delgado, X. Calvet, 2008, The American Journal of Gastroenterology.

Two‐week dual vs. one‐week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial

X. Calvet, E. Molina, M. Baré, 1999, Alimentary pharmacology & therapeutics.

Real-Time PCR Improves Helicobacter pylori Detection in Patients with Peptic Ulcer Bleeding

A. Montserrat, L. Boix, M. Gallach, 2011, PloS one.

Rapid Identification of Viable H. pylori Cells in Feces by DVCFISH

X. Calvet, M. Ramírez, Mª Yolanda Moreno Trigos, 2015 .

Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers.

J. Gisbert, M. Vergara, X. Calvet, 2004, Gastroenterology.

microRNA profiling in duodenal ulcer disease caused by Helicobacter pylori infection in a Western population.

A. Montserrat, X. Calvet, A. Aransay, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Variability in microRNA recovery from plasma: Comparison of five commercial kits.

X. Calvet, S. Lario, M. J. Ramírez-Lázaro, 2015, Analytical biochemistry.

OP20 Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study

C. I. Rodriguez, X. Calvet, F. Gomollón, 2021 .

Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989–2013): A Nationwide Multicenter Study

X. Calvet, I. Ordás, J. Panés, 2017, The American Journal of Gastroenterology.

Proton pump inhibitors versus H2‐antagonists: a meta‐analysis of their efficacy in treating bleeding peptic ulcer

J. Gisbert, X. Calvet, J. Pajares, 2001, Alimentary pharmacology & therapeutics.

Meta‐analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer

A. Barkun, M. Gallach, X. Calvet, 2011, Alimentary pharmacology & therapeutics.

Proton pump inhibitors versus H2 antagonists. A meta-analysis of its efficacy on bleeding peptic ulcer

J. Gisbert, X. Calvet, J. Pajares, 2001 .

A randomized study of the safety of outpatient care for patients with bleeding peptic ulcer treated by endoscopic injection.

X. Calvet, E. Brullet, R. Campo, 2004, Gastrointestinal endoscopy.

X. Calvet, E. Brullet, R. Campo, 1996, Gut.

Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer.

M. Rué, X. Calvet, L. Donoso, 1996, Gastrointestinal endoscopy.

[Oesophageal diseases: gastroesophageal reflux disease, Barrett's disease, achalasia and eosinophilic oesophagitis].

X. Calvet, 2015, Gastroenterologia y hepatologia.

Usefulness of endoscopic band ligation for bleeding small bowel vascular lesions.

M. Vergara, X. Calvet, F. Junquera, 2003, Gastrointestinal endoscopy.

Dealing with uncertainty in the treatment of Helicobacter pylori

X. Calvet, 2018, Therapeutic advances in chronic disease.

Meta-analysis: comparative efficacy of H2-receptor antagonists and proton pump inhibitors for reducing aspiration risk during anaesthesia depending on the administration route and schedule.

J. Sánchez-Delgado, X. Calvet, I. Puig, 2012, Pharmacological research.

Disease severity in familial cases of IBD.

J. Gisbert, X. Calvet, J. Panés, 2014, Journal of Crohn's & colitis.

Disease severity infamilial casesofIBD

X. Calvet, M. Andreu, A. Gutiérrez, 2014 .

Review article: non‐bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori

J. Gisbert, X. Calvet, J. Gisbert, 2011, Alimentary pharmacology & therapeutics.

Surgical resection and survival in Western patients with hepatocellular carcinoma.

J. Bruix, J. Visa, L. Boix, 1992, Journal of hepatology.

Meta‐analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users

J. Gisbert, M. Vergara, X. Calvet, 2005, Alimentary pharmacology & therapeutics.

Heterogeneity of clinical management of low-grade gastric lymphoma of mucosa-associated lymphoid tissue. An audit of 198 patients in Spain

J. Gisbert, X. Calvet, D. Nicolás-Pérez, 2020, Gastroenterología y Hepatología (English Edition).

Heterogeneity of clinical management of low-grade gastric lymphoma of mucosa-associated lymphoid tissue. An audit of 198 patients in Spain.

J. Gisbert, X. Calvet, D. Nicolás-Pérez, 2019, Gastroenterologia y hepatologia.

Review article: common misconceptions in the management of Helicobacter pylori‐associated gastric MALT‐lymphoma

J. Gisbert, X. Calvet, J. Gisbert, 2011, Alimentary pharmacology & therapeutics.

Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study.

M. Sans, X. Calvet, L. Bujanda, 2010, Journal of Crohn's & colitis.

Development and validation of the Crohn's disease perceived work disability questionnaire

F. Casellas, A. Montserrat, M. Vergara, 2011, Inflammatory bowel diseases.

Switching to a second thiopurine in adult and elderly patients with inflammatory bowel disease: a nationwide study from the ENEIDA registry.

J. Gisbert, X. Calvet, S. Riestra, 2020, Journal of Crohn's & colitis.

Increased risk of thiopurine‐related adverse events in elderly patients with IBD

J. Gisbert, X. Calvet, M. Mínguez, 2019, Alimentary pharmacology & therapeutics.

Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn’s Disease Recurrence. A GETECCU Randomised Trial

J. Gisbert, X. Calvet, J. Barrio, 2017, Journal of Crohn's & colitis.

Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry

X. Calvet, L. Bujanda, J. Barrio, 2019, Surgical Endoscopy.

A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel Disease.

M. Sanchez-Lloansí, X. Calvet, A. Villòria, 2019, Inflammatory bowel diseases.

Meta‐analysis: esomeprazole or rabeprazole vs. first‐generation pump inhibitors in the treatment of Helicobacter pylori infection

J. Gisbert, X. Calvet, O. Nyssen, 2012, Alimentary pharmacology & therapeutics.

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori

J. Gisbert, X. Calvet, 2012, Clinical and experimental gastroenterology.

The sequential therapy regimen for Helicobacter pylori eradication

F. Mégraud, C. O'Morain, J. Gisbert, 2010, Expert opinion on pharmacotherapy.

Topical pharyngeal anesthesia improves tolerance of upper gastrointestinal endoscopy: a randomized double-blind study.

A. Montserrat, C. Brotons, X. Calvet, 1995, Endoscopy.

Helicobacter pylori inactivation and virulence gene damage using a supported sensitiser for photodynamic therapy.

J. Gisbert, X. Calvet, D. García‐Fresnadillo, 2013, European journal of medicinal chemistry.

Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice

J. Gisbert, X. Calvet, J. Barrio, 2013, Gut.

Sa1882 Phase IV, Prospective, Randomized and Comparative Study Between Sequential and Concomitant Therapy for Helicobacter pylori Eradication in Routine Clinical Practice

J. Gisbert, X. Calvet, Blanca Belloc, 2013 .

Su1681 Meta-Analysis of Studies Comparing the First and New Generation Proton Pump Inhibitors in the Eradication of Helicobacter pylori

J. Gisbert, X. Calvet, O. Nyssen, 2012 .

Meta-Analysis: Rabeprazole and Esomeprazole in the Eradication of Helicobacter pylori

J. Gisbert, X. Calvet, O. Nyssen, 2011 .

P289 Evaluation of the safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease: National multicenter study (ENEIDA registry). MIC project

X. Calvet, M. Piqueras, F. Mesonero, 2022, Journal of Crohn's and Colitis.

A Nurse-Driven Outpatient Clinic for Thiopurine-Treated Inflammatory Bowel Disease Patients Reduces Physician Visits and Increases Follow-Up Efficiency

A. Dosal, X. Calvet, María López, 2015, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.

Two-day quadruple therapy for cure of helicobacter pylori infection: a comparative, randomized trial

X. Calvet, R. Comet, E. Brullet, 1998, American Journal of Gastroenterology.

Systematic Review and Meta‐analysis: Proton Pump Inhibitor vs. Ranitidine Bismuth Citrate Plus Two Antibiotics in Helicobacter pylori Eradication

J. Gisbert, X. Calvet, L. González, 2005, Helicobacter.

Inter and intra-observer concordance for the diagnosis of portal hypertension gastropathy.

M. Vergara, M. Miquel, M. Casas, 2018, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Plasma sample based analysis of gastric cancer progression using targeted metabolomics

X. Calvet, S. Lario, M. J. Ramírez-Lázaro, 2017, Scientific Reports.

Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry.

X. Calvet, S. Lario, M. J. Ramírez-Lázaro, 2016, Journal of proteome research.

Safe Prescription Recommendations for Non Steroidal Anti-inflammatory Drugs: Consensus Document Elaborated by Nominated Experts of Three Scientific Associations (SER-SEC-AEG)

Á. Lanas, X. Calvet, G. Barón-Esquivias, 2014 .

Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.

J. Gisbert, X. Calvet, M. Piqueras, 2023, The American journal of gastroenterology.

Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation

J. Gisbert, X. Calvet, D. Busquets, 2017, Digestive Diseases and Sciences.

Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases.

J. Bruix, J. Rodés, X. Calvet, 1990, Journal of hepatology.

Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection.

J. Gisbert, Á. Lanas, X. Calvet, 2019, Gastroenterology & hepatology.

Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal.

A. Montserrat, J. Sánchez-Delgado, X. Calvet, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Value and limitations of cytologic criteria for the diagnosis of hepatocellular carcinoma by fine needle aspiration biopsy.

J. Bruix, X. Calvet, M. Solé, 1993, Acta cytologica.

Whole-Genome Sequencing and Comparative Genomics of Three Helicobacter pylori Strains Isolated from the Stomach of a Patient with Adenocarcinoma

X. Calvet, S. Lario, M. J. Ramírez-Lázaro, 2021, Pathogens.

Analysis of the association between fatigue and the plasma lipidomic profile of inflammatory bowel disease patients.

Juan Daniel Sanjuan-Herráez, X. Calvet, S. Lario, 2020, Journal of proteome research.

Diagnostic utility of nasogastric tube aspiration and the ratio of blood urea nitrogen to creatinine for distinguishing upper and lower gastrointestinal tract bleeding.

X. Calvet, R. Campo, E. Brullet, 2018, Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias.

Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.

Á. Lanas, X. Calvet, L. Bujanda, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

UTILITY OF SHOCK INDEX FOR RISK STRATIFICATION IN ACUTE LOWER GASTROINTESTINAL BLEEDING

X. Calvet, F. Junquera, E. Brullet, 2020, Endoscopy.

Urticarial reaction to oral polyethylene glycol electrolyte lavage solution.

X. Calvet, A. Moron, E. Brullet, 1992, Gastrointestinal endoscopy.

IV Spanish Consensus Conference on Helicobacter pylori infection treatment.

J. Gisbert, Á. Lanas, F. Mearin, 2016 .

Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment.

J. Gisbert, J. Sánchez-Delgado, X. Calvet, 2016, The Journal of antimicrobial chemotherapy.

Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

J. Gisbert, X. Calvet, J. Gisbert, 2012, Alimentary pharmacology & therapeutics.

Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection.

J. Gisbert, J. Sánchez-Delgado, X. Calvet, 2015, The Journal of antimicrobial chemotherapy.

How to compare biologic drugs.

J. Esplugues, X. Calvet, 2014, Reumatologia clinica.

Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study

J. Gisbert, X. Calvet, J. Panés, 2016, The American Journal of Gastroenterology.

Fatigue in out-patients with inflammatory bowel disease: Prevalence and predictive factors

A. Montserrat, A. Dosal, X. Calvet, 2017, PloS one.

Infliximab Maintenance Therapy Is Associated With Decreases in Direct Resource Use in Patients With Luminal or Fistulizing Crohn's Disease

F. Casellas, J. Gisbert, X. Calvet, 2009, Journal of clinical gastroenterology.

Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions

J. Gisbert, M. Ricote, X. Calvet, 2019, Helicobacter.

Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE survey.

X. Calvet, A. López-Sanromán, F. Argüelles-Arias, 2017, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Corrigendum: Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study

J. Gisbert, X. Calvet, J. Panés, 2016, The American Journal of Gastroenterology.

Immune thrombocytopenic purpura associated with Crohn's disease with complete response to infliximab.

X. Calvet, P. García-Iglesias, E. Brunet, 2019, Gastroenterologia y hepatologia.

Immune thrombocytopenic purpura associated with Crohn's disease with complete response to infliximab.

X. Calvet, P. García-Iglesias, E. Brunet, 2019, Gastroenterologia y hepatologia.

P774 Low adhesion to latent tuberculosis (TB) screening recommendations in inflammatory bowel disease (IBD) patients: Results of the INFEII registry of GETECCU

J. Gisbert, X. Calvet, M. Piqueras, 2020 .

Systematic review, meta‐analysis, and meta‐regression: Successful second‐line treatment for Helicobacter pylori

J. Sánchez-Delgado, X. Calvet, I. Puig, 2018, Helicobacter.

Could Increasing the Duration of Triple Therapy Be a Clinically Useful Strategy?

M. Vergara, X. Calvet, A. Villòria, 2008, Annals of Internal Medicine.

Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.

J. Gisbert, X. Calvet, M. Chaparro, 2020, The American journal of gastroenterology.

Phase II study of transarterial embolization in european patients with hepatocellular carcinoma: Need for controlled trials

L. Jover, J. Bruix, L. Boix, 1994, Hepatology.

Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation.

J. Bruix, J. Rodés, X. Calvet, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Meta‐analysis: high‐dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication

J. Gisbert, M. Vergara, X. Calvet, 2008, Alimentary pharmacology & therapeutics.

Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)

J. Gisbert, E. Rey, X. Calvet, 2016, United European gastroenterology journal.

Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough

J. Gisbert, X. Calvet, J. Gisbert, 2011, Alimentary pharmacology & therapeutics.

Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta‐analysis

J. Gisbert, M. Vergara, X. Calvet, 2002, Alimentary pharmacology & therapeutics.

Gastroenterologists’ attitudes on the detection and management of gastric premalignant conditions: results of a nationwide survey in Spain

X. Calvet, G. Fernández-Esparrach, H. Córdova, 2020, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Proton pump inhibitor versus ranitidine bismuth citrate plus two antibiotics for one week. A meta-analysis of its efficacy on Hericobacter pylori eradication

J. Gisbert, X. Calvet, J. Pajares, 2000 .

Prevalence of Helicobacter pylori resistance after failure of first-line therapy. A systematic review

J. Sánchez-Delgado, X. Calvet, M. Baylina, 2018, Gastroenterología y Hepatología (English Edition).

Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis

J. Gisbert, X. Calvet, J. Pajares, 2004, European journal of gastroenterology & hepatology.

Ranitidine–bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study

A. Montserrat, M. Vergara, X. Calvet, 2004, European journal of gastroenterology & hepatology.

Diagnostic accuracy of three monoclonal stool tests in a large series of untreated Helicobacter pylori infected patients.

A. Montserrat, X. Calvet, S. Lario, 2016, Clinical biochemistry.

Cólico hepático por paracetamol-codeína

A. Montserrat, M. Vergara, B. Dalmau, 2001 .

Manejo de la hemorragia digestiva baja aguda: documento de posicionamiento de la Societat Catalana de Digestologia.

M. Gallach, X. Calvet, E. Espı́n, 2013 .

[Management of acute lower gastrointestinal hemorrhage: position statement of the Catalan Society of Gastroenterology].

M. Gallach, X. Calvet, E. Espı́n, 2013, Gastroenterologia y hepatologia.

Prevalence of Helicobacter pylori infection in the Vallès Occidental, Catalonia

X. Calvet, F. Segura, I. Sanfeliú, 1999 .

Diagnosis of Helicobacter pylori Infection in the Proton Pump Inhibitor Era.

X. Calvet, 2015, Gastroenterology clinics of North America.

Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients

J. Gisbert, X. Calvet, L. Rodrigo, 2008, The American Journal of Gastroenterology.

[Helicobacter pylori does not contribute to iron deficiency in hemodialysis patients].

X. Calvet, J. Almirall, F. Segura, 2006, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy (with or without long‐term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer

J. Gisbert, X. Calvet, F. Carballo, 2004 .

Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis

M. Vergara, X. Calvet, M. Roqué, 2002, European journal of gastroenterology & hepatology.

Dual Versus Endoscopic Monotherapy in Bleeding Peptic Ulcers

J. Gisbert, M. Vergara, X. Calvet, 2007, The American Journal of Gastroenterology.

Endoscopist’s Judgment Is as Useful as Risk Scores for Predicting Outcome in Peptic Ulcer Bleeding: A Multicenter Study

X. Calvet, M. Papo, M. Planella, 2020, Journal of clinical medicine.

Usefulness of a delayed test for the diagnosis of Helicobacter pylori infection in bleeding peptic ulcer

J. Sánchez-Delgado, X. Calvet, E. Artigau, 2006, Alimentary pharmacology & therapeutics.

An optimized clarithromycin-free 14-day triple therapy for Helicobacter pylori eradication achieves high cure rates in Uruguay.

J. Sánchez-Delgado, X. Calvet, H. Balter, 2017, Gastroenterologia y hepatologia.

Epidemiology of peptic ulcer disease in cirrhotic patients: role of helicobacter pylori infection

B. Dalmau, X. Calvet, M. Gil, 1998, American Journal of Gastroenterology.

Comparable Quality of Bowel Preparation With Single‐Day Versus Three‐Day Low‐residue Diet: A Randomized Controlled Tria

X. Calvet, N. Piqué, A. Selva, 2020, Endoscopy.

Proton pump inhibitor‐based triple therapies versus dual therapies for Helicobacter pylori eradication

X. Calvet, P. Sutton, K. Hashmi, 2013 .

[Helicobacter pylori infection and functional dyspepsia. Meta-analysis of efficacy of eradication therapy].

J. Gisbert, X. Calvet, J. Pajares, 2002, Medicina clinica.

Gastric ulcer penetrating to the liver: endoscopic diagnosis.

X. Calvet, A. Giménez, E. Brullet, 1993, The American journal of gastroenterology.

Comparative accuracy of 3 monoclonal stool tests for diagnosis of Helicobacter pylori infection among patients with dyspepsia.

A. Montserrat, M. Gallach, M. Miquel, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pylori infection in patients with upper gastrointestinal bleeding

X. Calvet, J. Mendoza, M. Quesada, 2004, Alimentary pharmacology & therapeutics.

[Evaluation of a rapid test (ImmunoCard STAT! HpSA) for Helicobacter pylori detection in stools].

A. Montserrat, X. Calvet, F. Segura, 2003, Gastroenterology & hepatology.

Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection: Time Trends in a Spanish Multicenter Study of 1000 Patients

J. Gisbert, X. Calvet, L. Rodrigo, 2013, Journal of clinical gastroenterology.

Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection

J. Gisbert, Á. Lanas, X. Calvet, 2020, Gastroenterología y Hepatología (English Edition).

Update on the management of Helicobacter pylori infection. Position paper from the Catalan Society of Digestology

J. Gisbert, X. Calvet, I. Puig, 2018 .

Key Points for Designing and Reporting Helicobacter pylori Therapeutic Trials: A Personal View

J. Gisbert, X. Calvet, David Suárez, 2011, Helicobacter.

Usefulness of Non‐invasive Tests for Diagnosing Helicobacter pylori Infection in Patients Undergoing Dialysis for Chronic Renal Failure

X. Calvet, J. Almirall, F. Segura, 2004, Helicobacter.

Seven-day versus 10- to 14-day therapies with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Hericobacter pylori infection. A metaanalysis

J. Gisbert, X. Calvet, E. Gené, 2000 .

H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.

J. Gisbert, X. Calvet, F. Carballo, 2003, The Cochrane database of systematic reviews.

[Testing a new in-office test for determination of faecal Helicobacter pylori antigen].

A. Montserrat, X. Calvet, J. Real, 2002, Medicina clinica.

[The evaluation of a new immunoenzyme analysis for the detection of Helicobacter pylori infection in stool samples].

A. Montserrat, X. Calvet, J. Domínguez, 1999, Gastroenterologia y hepatologia.

Prevalence of Helicobacter pylori resistance after failure of first-line therapy. A systematic review.

J. Sánchez-Delgado, X. Calvet, M. Baylina, 2018, Gastroenterology & hepatology.

Systematic review: Would susceptibility‐guided treatment achieve acceptable cure rates for second‐line Helicobacter pylori therapy as currently practiced?

J. Sánchez-Delgado, X. Calvet, I. Puig, 2019, Helicobacter.

Optimum second-line regimens for Helicobacter pylori eradication

J. Gisbert, Yuhong Yuan, G. Leontiadis, 2014 .

P372 Prospective, randomized clinical trial comparing the efficacy of two vaccines against hepatitis B virus (HBV) in inflammatory bowel disease (IBD) patients

J. Mate, J. Gisbert, X. Calvet, 2014 .

Seven versus Ten Days of Rabeprazole Triple Therapy for Helicobacter pylori Eradication: A Multicenter Randomized Trial

A. Montserrat, X. Calvet, L. Bujanda, 2005, The American Journal of Gastroenterology.

7‐day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure

J. Gisbert, X. Calvet, J. Guardiola, 2005, Alimentary pharmacology & therapeutics.

Su1686 The Effectiveness of Standard Triple-Therapy for Helicobacter pylori Has Not Changed Over the Last Decade, but it is Not Good Enough

J. Gisbert, X. Calvet, 2012 .

V Spanish Consensus Conference on Helicobacter pylori infection treatment.

J. Gisbert, Á. Lanas, X. Calvet, 2021, Gastroenterologia y hepatologia.

[III Spanish Consensus Conference on Helicobacter pylori infection].

J. Gisbert, Á. Lanas, F. Mearin, 2013, Gastroenterologia y hepatologia.

[Management of Helicobacter pylori infection in primary care in Spain].

J. Sánchez-Delgado, X. Calvet, R. Azagra, 2008, Gastroenterologia y hepatologia.

[Fulminant infection caused by varicella herpes zoster in patient with Crohn disease undergoing treatment with azathioprine].

M. Vergara, X. Calvet, E. Brullet, 2001, Gastroenterologia y hepatologia.

Diagnosis of Helicobacter pylori infection in dyspeptic patients by stool antigen detection usefulness of a new monoclonal enzyme immunoassay test.

A. Montserrat, X. Calvet, F. Segura, 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort study

J. Gisbert, X. Calvet, A. Villòria, 2009, Annals of Hematology.

Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta‐analysis

X. Calvet, E. Gené, R. Azagra, 2003, Alimentary pharmacology & therapeutics.

Letter: the irony of oral iron – not an underdog for post‐gastrointestinal bleeding anaemia

X. Calvet, J. Molina-Infante, J. Gisbert, 2014, Alimentary pharmacology & therapeutics.

Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU

J. Gisbert, X. Calvet, M. Piqueras, 2021, American Journal of Gastroenterology.

Esophagitis in a High H. pylori Prevalence Area: Severe Disease Is Rare but Concomitant Peptic Ulcer Is Frequent

M. Gallach, X. Calvet, M. Ponce, 2011, PloS one.

Meta‐analysis: comparative efficacy of different proton‐pump inhibitors in triple therapy for Helicobacter pylori eradication

J. Gisbert, M. Vergara, X. Calvet, 2003, Alimentary pharmacology & therapeutics.

Do proton pump inhibitors increase the risk of myocardial infarction

X. Calvet, P. García-Iglesias, D. Horta, 2016 .

Do proton pump inhibitors increase the risk of myocardial infarction

X. Calvet, P. García-Iglesias, D. Horta, 2016 .

Helicobacter pylori does not play a part in the dyspeptic complaints of rheumatology patients receiving long term treatment with non-steroidal anti-inflammatory drugs

X. Calvet, I. Sanfeliú, M. Roqué, 2002, Annals of the rheumatic diseases.

High Effectiveness of a 14-Day Concomitant Therapy for Helicobacter pylori Treatment in Primary Care. An Observational Multicenter Study

X. Calvet, R. Azagra, A. Aguyé, 2020, Journal of clinical medicine.

Fourth‐line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures

X. Calvet, J. Molina-Infante, I. Modolell, 2012, Alimentary pharmacology & therapeutics.

What is the best strategy for diagnosis and treatment of Helicobacter pylori in the prevention of recurrent peptic ulcer bleeding? A cost-effectiveness analysis.

J. Gisbert, J. Sánchez-Delgado, X. Calvet, 2009, Value in Health.

What Is the Best Strategy for Diagnosis andTreatment of Helicobacter pylori in the Prevention of Recurrent Peptic Ulcer Bleeding ? A Cost-Effectiveness

J. Gisbert, J. Sánchez-Delgado, X. Calvet, 2010 .

P397 Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry

J. Gisbert, X. Calvet, M. Piqueras, 2018 .

Effectiveness of a Dose “De-Escalation” Strategy With Anti-TNF Drugs in Patients With Crohn's Disease (CD)

J. Gisbert, X. Calvet, M. Chaparro, 2011 .

What is the best first-line therapy for Helicobacter pylori infection?

X. Calvet, 2008, Nature Clinical Practice Gastroenterology &Hepatology.

Helicobacter pylori Infection: Treatment Options

X. Calvet, 2006, Digestion.

[Guidelines for the diagnosis and treatment of acute non-variceal upper gastrointestinal bleeding].

J. Guardiola, X. Calvet, E. Saperas, 2003, Gastroenterologia y hepatologia.

H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.

J. Gisbert, X. Calvet, F. Carballo, 2004, The Cochrane database of systematic reviews.

Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication.

J. Gisbert, X. Calvet, J. Pajares, 2003, Alimentary pharmacology & therapeutics.

Genetic variation analysis in a follow‐up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14

J. Gisbert, C. González, J. Sanz-Anquela, 2018, International journal of cancer.

[Seven-day omeprazole, clarithromycin, and amoxicillin for the therapy of Helicobacter pylori infection].

X. Calvet, R. Comet, I. Sanfeliú, 1998, Gastroenterologia y hepatologia.

[Coordination between primary and specialized care in gastroenterology is insufficient. A survey of gastroenterologists and general practitioners].

X. Calvet, R. Azagra, E. Gené, 2010, Gastroenterologia y hepatologia.

Update on the management of Helicobacter pylori infection. Position paper from the Catalan Society of Digestology.

J. Gisbert, X. Calvet, I. Puig, 2018, Gastroenterologia y hepatologia.

Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

F. Mégraud, C. O'Morain, J. Gisbert, 2023, Gut.

High-dose vs non-high-dose PPIs after endoscopic treatment in patients with bleeding peptic ulcer: current evidence is insufficient to claim equivalence.

E. Kuipers, A. Barkun, X. Calvet, 2010, Archives of internal medicine.

Outcomes of Peptic Ulcer Bleeding After Treatment With Intravenous Proton Pump Inhibitors in Routine Clinical Practice

Á. Lanas, X. Calvet, L. Bujanda, 2011 .

Esophageal, Gastric and Duodenal Disorders / Helicobacter pylori: Diagnosis, Treatment and Antimicrobial ResistanceEradication of Helicobacter pylori for the Prevention of Peptic Ulcer Rebleeding. Long-Term Follow-up Study of 890 Patients

J. Gisbert, X. Calvet, J. Piqué, 2011 .

Nasogastric intubation in patients with upper gastrointestinal bleeding

X. Calvet, E. Gené, 2016 .

[Sedation in digestive endoscopy. Results of a hospital survey in Catalonia (Spain)].

M. Vergara, X. Calvet, F. Junquera, 2004, Gastroenterology & hepatology.

The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD)

C. Lees, F. Underwood, G. Kaplan, 2022, The American journal of gastroenterology.

Coding and non-coding co-expression network analysis identifies key modules and driver genes associated with precursor lesions of gastric cancer.

X. Calvet, A. Aransay, S. Lario, 2022, Genomics.

Effectiveness and safety of methotrexate monotherapy in patients with Crohn’s disease refractory to anti‐TNF‐α: results from the ENEIDA registry

J. Gisbert, X. Calvet, J. Tosca, 2021, Alimentary pharmacology & therapeutics.

Diagnosis of Helicobacter pylori after triple therapy in uncomplicated duodenal ulcers—a cost‐effectiveness analysis

X. Calvet, R. Azagra, E. Gené, 2000, Alimentary pharmacology & therapeutics.

OP034 The initiation of thiopurines in elderly patients with inflammatory bowel disease is associated with an increased risk of adverse effects: a case–control study of the ENEIDA registry

J. Gisbert, X. Calvet, J. Panés, 2018 .

T1943 Is H. pylori Testing Clinically Useful in the Acute Setting of Upper Gastrointestinal Bleeding? a Systematic Review

E. Kuipers, A. Barkun, Á. Lanas, 2009 .

[Nasogastric intubation in patients with upper gastrointestinal bleeding?].

X. Calvet, E. Gené, 2016, Gastroenterologia y hepatologia.

Safe prescription recommendations for non steroidal anti-inflammatory drugs: consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG).

Á. Lanas, X. Calvet, G. Barón-Esquivias, 2014, Reumatologia clinica.

[Esophageal diseases: gastroesophageal reflux disease, Barrett's esophagus and eosinophilic esophagitis].

X. Calvet, 2011, Gastroenterologia y hepatologia.

Droplet Digital PCR Detects Low-Density Infection in a Significant Proportion of Helicobacter Pylori-Negative Gastric Biopsies of Dyspeptic Patients

A. Montserrat, X. Calvet, S. Lario, 2020, Clinical and translational gastroenterology.

Occult H. pylori infection partially explains ‘false-positive’ results of 13C-urea breath test

A. Montserrat, J. Sánchez-Delgado, X. Calvet, 2015, United European gastroenterology journal.

Patients’ perceptions of the impact of ulcerative colitis on social and professional life: results from the Uc-liFe survey of outpatient clinics in spain

X. Calvet, F. Argüelles-Arias, D. Carpio, 2018 .

Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata

Á. Lanas, X. Calvet, J. Calleja, 2014, Scandinavian journal of gastroenterology.

QUALITY IN DIAGNOSTIC UPPER GASTROINTESTINAL ENDOSCOPY FOR THE DETECTION AND SURVEILLANCE OF GASTRIC CANCER PRECURSOR LESIONS: POSITION PAPER OF AEG, SEED AND SEAP.

J. Cubiella, X. Calvet, L. Moreira, 2021, Gastroenterologia y hepatologia.

Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU

J. Gisbert, X. Calvet, M. Piqueras, 2022, The American journal of gastroenterology.

Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent.

J. Gisbert, X. Calvet, M. Chaparro, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prevalence of Helicobacter pylori resistance after failure of first-line therapy. A systematic review.

J. Sánchez-Delgado, X. Calvet, M. Baylina, 2018, Gastroenterologia y hepatologia.

V Spanish Consensus Conference on Helicobacter pylori infection treatment.

J. Gisbert, Á. Lanas, X. Calvet, 2021, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

J. Gisbert, X. Calvet, J. Tosca, 2017, The American Journal of Gastroenterology.

Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study

J. Gisbert, X. Calvet, J. Panés, 2009, The American Journal of Gastroenterology.